{"store":{"baseInfo":{"podcastTitle":"Gut Podcast","slug":"gutbmj","podcastDescription":"Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gastroenterology (FG). \nThe Gut Podcast discusses highlights from its issues monthly. Please subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.","podcastLogo":"https://deow9bq0xqvbj.cloudfront.net/image-logo/16464245/Gut.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464245/Gut_1200x628.jpg?s=2527b4d3cf20998b44daa2e9e65b5c04&e=jpg","podcastUrl":"https://gutbmj.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/gutbmj/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-tp4wa-fb3975","removePodbeanBranding":"yes","brandingLogo":null,"timeZone":{"timeZoneId":30,"gmtAdjustment":"GMT+00:00","useDaylightTime":1,"value":0,"text":"(GMT+00:00) Greenwich Mean Time : Dublin, Edinburgh, Lisbon, London","daylightStartTime":"Last Sunday of March +1 Hours","daylightEndTime":"Last Sunday Of October +1 Hours","timezone":"Europe/London"},"podcastDownloads":null,"totalEpisodes":104,"showComments":false,"iOSAppDownloadLink":null,"customizeCssUrl":"https://s3.amazonaws.com/user-css.podbean.com/16464245/elegant/style.css","androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"BMJ Group","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-tp4wa-fb3975-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/gut-podcast/id330976727","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fgutbmj.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16464245%26podcastIdTag%3Dtp4wa&dfl=https%3A%2F%2Fgutbmj.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/33PdKlxZivzvXD3DM1FUK4","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/spotify.png","title":null},{"name":"Amazon Music","link":"https://music.amazon.com/podcasts/dc87475d-54c4-4b04-a4bb-4ebe5aade5a6","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/AmazonMusic.png","title":null},{"name":"TuneIn + Alexa","link":"https://tunein.com/podcasts/Gut-podcast-p985148","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/tunein.png","title":null},{"name":"iHeartRadio","link":"https://iheart.com/podcast/116261054","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/iHeartRadio.png","title":null},{"name":"PlayerFM","link":"https://player.fm/series/3480506","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/PlayerFM.png","title":null},{"name":"Listen Notes","link":"https://www.listennotes.com/podcasts/gut-podcast-bmj-group-xE3oXZVJNWG/","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/ListenNotes.png","title":null},{"name":"Samsung","link":null,"image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/Samsung.png","title":"Search the podcast title on Samsung Podcast app."},{"name":"Podchaser","link":"https://www.podchaser.com/podcasts/gut-podcast-151751","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/Podchaser.webp","title":null},{"name":"BoomPlay","link":"https://www.boomplaymusic.com/podcasts/67854","image":"https://d8g345wuhgd7e.cloudfront.net/site/images/admin5/BoomPlay.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#F7991E"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"hide"},{"id":"Favicon","val":"https://mcdn.podbean.com/mf/web/ktcya3/Gut.jpg"},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"hide"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/w3nmbnUqgu83","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-M9JKloTW5FLG","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[{"id":"ComponentText-4061497d-c177-d4d1-3da9-7a082f273c67","val":{"ComponentFontColor":"#000000","ComponentBackgroundColor":"#f2f2f2","ComponentContent":"

* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

"}}]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.generic","app_store_id":1484287462,"app_name":"Podbean Biz Podcast App","scheme":"enterprise-podbean-com"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":false,"enableWebSiteLike":false},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://gutbmj.podbean.com","apiCommonParams":{"t":"662eb7eb","clientSignature":"9eb66b6936f0e9523ac80aaaa5999066","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":null,"commentsTotalPage":null,"commentsPage":null,"commentEpisodeId":null,"episode":{"id":"pb21026221","idTag":"nqas9","title":"Mesalazine and thymoquinone attenuate intestinal tumour development in mice","logo":"https://deow9bq0xqvbj.cloudfront.net/image-logo/16464245/Gut_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464245/Gut_1200x628.jpg?s=2527b4d3cf20998b44daa2e9e65b5c04&e=jpg","largeLogo":"https://deow9bq0xqvbj.cloudfront.net/image-logo/16464245/Gut.jpg","previewContent":null,"content":"In this podcast Dr Mairi McLean talks to Dr Christoph Gasche about his editors choice paper \"Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice.\"\n\n

Full paper >> http://gut.bmj.com/content/64/12/1905.full

","publishTimestamp":1457449800,"duration":1146,"mediaUrl":"https://mcdn.podbean.com/mf/web/w73gs7/stream_250838332-bmjgroup-mesalazine-and-thymoquinone-attenuate-intestinal-tumour-development-in-mice.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-nqas9-140d5ad","likedCount":null,"deepLink":"https://www.podbean.com/ew/pb-nqas9-140d5ad","transcriptUrl":null,"permalink":"/e/mesalazine-and-thymoquinone-attenuate-intestinal-tumour-development-in-mice/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB140D5ADNQAS9","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":0,"status":"publish","hasMoreContent":false,"chaptersUrl":null},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-nqas9-140d5ad","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000},"episode":{"id":"pb21026221","idTag":"nqas9","title":"Mesalazine and thymoquinone attenuate intestinal tumour development in mice","logo":"https://deow9bq0xqvbj.cloudfront.net/image-logo/16464245/Gut_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464245/Gut_1200x628.jpg?s=2527b4d3cf20998b44daa2e9e65b5c04&e=jpg","largeLogo":"https://deow9bq0xqvbj.cloudfront.net/image-logo/16464245/Gut.jpg","previewContent":null,"content":"In this podcast Dr Mairi McLean talks to Dr Christoph Gasche about his editors choice paper \"Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice.\"\n\n

Full paper >> http://gut.bmj.com/content/64/12/1905.full